Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies.

Authors:
Sang-Hoon Sin
Sang-Hoon Sin
Dept. Microbiology & Immunology / University of North Carolina at Chapel Hill
Research Assistant Professor
KSHV
Chapel Hill, NC | United States

Int J Cancer 2012 Jun 29;130(11):2728-33. Epub 2011 Aug 29.

The Viral Oncology Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

The nuclear factor kappa B (NFκB) pathway is essential for many human cancers. Therapeutics such as bortezomib (Velcade™) that interfere with NFκB signaling are of great clinical interest. NFκB signaling, however, is multifaceted and variable among tissues, developmental and disease entities. Hence, targeted biomarkers of NFκB pathways are of prime importance for clinical research. We developed a novel real-time qPCR-based NFκB array. Only mechanistically validated NFκB targets were included. We then used random-forest classification to define individual genes and gene combinations within the NFκB pathways that define viral lymphoma subclasses as well as Kaposi sarcoma (KS). Few NFκB targets emerged that were universally present in all tumor types tested, underscoring the need for additional tumor-type specific biomarker discovery. (i) We uncovered tissue of origin-specific tumor markers, specifically CD69, CSF-1 and complement factor B (C1QBP) for primary effusion lymphoma (PEL); IL1-beta, cyclinD3 and CD48 for KS. We found that IL12, jun-B, msx-1 and thrombospondin 2 were associated with EBV co-infection in PEL. (ii) We defined the NFκB signature of Epstein-Barr virus (EBV) positive AIDS-associated Burkitt lymphoma (BL). This signature identified CCR5 as the key marker. (iii) This signature differed from EBV negative BL consistent with the idea that EBV not only activates NFκB activity but that this virus also reprograms NFκB signaling toward different targets.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265660PMC
June 2012
21 Reads
5.085 Impact Factor

Publication Analysis

Top Keywords

nfκb signaling
12
nfκb
11
nfκb pathways
8
nfκb targets
8
factor kappa
8
nuclear factor
8
lymphoma subclasses
4
subclasses well
4
positive aids-associated
4
pathways define
4
viral lymphoma
4
ebv positive
4
define viral
4
well kaposi
4
universally tumor
4
epstein-barr virus
4
tumor types
4
emerged universally
4
virus ebv
4
kaposi sarcoma
4

Similar Publications